NCT03076372 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03076372
Title	A Study Evaluating MM-310 in Patients With Solid Tumors
Recruitment	Unknown status
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Merrimack Pharmaceuticals
Indications	transitional cell carcinoma gastroesophageal junction adenocarcinoma head and neck squamous cell carcinoma triple-receptor negative breast cancer lung small cell carcinoma ovarian cancer pancreatic ductal adenocarcinoma sarcoma stomach carcinoma endometrial carcinoma esophageal carcinoma lung non-small cell carcinoma
Therapies	MM-310
Age Groups:	senior \| adult
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
Honor Health	RECRUITING	Scottsdale	Arizona	85259	United States	Details
University California San Francisco	RECRUITING	San Francisco	California	94143	United States	Details
Mayo Clinic	RECRUITING	Rochester	Minnesota	55902	United States	Details
Roswell Park Cancer Institute	RECRUITING	Buffalo	New York	14263	United States	Details
Duke University	RECRUITING	Durham	North Carolina	27710	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT03076372Clinical Trial Detail